Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PTSC Value....???

PTSC Value....???

posted on Jul 12, 2009 09:54PM

our last four 1/4's we show a profit of about 3.5 million.... we have about 5 cents a share in cash CNBC a few months ago said to figure out the PE you cash and asset per share from share price... .134-.05= .084 ... with a PE of 9 based on past earnings we are fairly valued.... so .. I guess we need to GROWTH... GROWTH in MMP .. GROWTH PDGS.. Growth Talis... GROWTH avot..... Growth Nu power,,,,

2009 Q3 2009 Q2 2009 Q1 2008 Q4 2008 Q3
Period End Date 02/28/2009 11/30/2008 08/31/2008 05/31/2008 02/29/2008
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Stmt Source 10-Q 10-Q 10-Q 10-K 10-Q
Stmt Source Date 04/09/2009 01/09/2009 10/10/2008 08/14/2008 04/09/2008
Stmt Update Type Updated Updated Updated Updated Updated
Revenue 1.41 1.88 1.36 1.44 0.8
Total Revenue 1.41 1.88 1.36 1.44 0.8
Cost of Revenue, Total 0.85 1.08 0.58 0.66 0.35
Gross Profit 0.56 0.8 0.78 0.78 0.46
Selling/General/Administrative Expenses, Total 2.09 2.18 1.93 1.66 1.36
Research & Development 0.12 0.15 0.0 0.0 0.0
Depreciation/Amortization 0.0 0.0 0.0 0.0 0.0
Interest Expense (Income), Net Operating 0.0 0.0 0.0 0.0 0.0
Unusual Expense (Income) 0.0 0.0 0.0 0.0 0.42
Other Operating Expenses, Total 0.0 0.0 0.0 0.0 0.0
Operating Income -1.64 -1.53 -1.16 -0.87 -1.33
Interest Income (Expense), Net Non-Operating 0.0 0.0 0.0 0.0 0.0
Gain (Loss) on Sale of Assets 0.0 0.0 0.0 0.0 0.0
Other, Net 0.06 0.0 0.0 0.0 0.0
Income Before Tax -2.53 -1.29 5.51 3.44 10.69
Income Tax - Total -1.11 -0.63 2.38 0.68 4.4
Income After Tax -1.42 -0.66 3.13 2.76 6.29
Minority Interest -0.07 -0.27 0.08 -0.12 0.0
Equity In Affiliates 0.0 0.0 0.0 0.0 0.0
U.S. GAAP Adjustment 0.0 0.0 0.0 0.0 0.0
Net Income Before Extra. Items -1.49 -0.93 3.21 2.64 6.29
Total Extraordinary Items 0.0 0.0 0.0 0.0 0.0
Net Income -1.49 -0.93 3.21 2.64 6.29
Share
New Message
Please login to post a reply